deltatrials
Unknown PHASE4 INTERVENTIONAL 1-arm NCT04555707

The Maintenance Effect of Enstilar Foam in Combination With Otezla

Sponsor: Derm Research, PLLC

Conditions Psoriasis
Interventions Apremilast 30mg calcipotriene and betamethasone dipropionate
Updated 6 times since 2020 Last updated: Oct 7, 2020 Started: Jun 24, 2020 Primary completion: Jun 30, 2021 Completion: Sep 30, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Psoriasis and is currently ongoing. Derm Research, PLLC leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshotRecruiting~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotRecruiting~Jan 2021 – ~Nov 2022 · 22 months · monthly snapshotRecruiting~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown Status → Unknown

  3. Nov 2022 — Jul 2024 [monthly]

    Unknown Status PHASE4

    Status: Recruiting → Unknown Status

  4. Jan 2021 — Nov 2022 [monthly]

    Recruiting PHASE4

  5. Nov 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

▶ Show 1 earlier version

  1. Oct 2020 — Nov 2020 [monthly]

    Recruiting PHASE4

    First recorded

Jun 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Derm Research, PLLC
Data source: Derm Research, PLLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations